Last Updated on October 10, 2024 by The Health Master
Download Draft Amendments in IP 2022: In a bid to control the microbial quality of pharmaceutical products, the Indian Pharmacopoeia Commission (IPC) has come up with a draft amendment to microbial contamination in non-sterile products in Indian Pharmacopoeia (IP) 2022.
The new draft amendment, released by IPC on October 26, 2022, introduced changes to the enumeration of aerobic microorganisms present in the product as well as modifications in microbial contamination in barium sulfate oral suspension, microcrystalline cellulose, and starch.
The draft amendment increased the number of colonies for the total fungal count to 50 from 25 in the pour-plate method used for the enumeration of aerobic microorganisms present in the product.
It says, “Then select the plates corresponding to a given dilution and showing the highest number of colonies but less than 250 for aerobic microorganisms and 50 colonies for the total fungal count.” Earlier it was 25 colonies for the total fungal count.
The draft says barium sulfate oral suspension should be free from contamination of Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa, Salmonella species.
Earlier IP stated that the total aerobic viable count is not more than 100 cfu per ml, the total combined molds and yeasts count is not more than 10 cfu per ml. 1 g is free from Staphylococcus aureus and Pseudomonas aeruginosa and 10 g is free from Salmonella species.
The new draft amendment says, “The total aerobic viable count is not more than 100 cfu per ml, the total combined molds and yeasts count is not more than 10 cfu per ml. 1 g is free from Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa and 10 g is free from Salmonella species.”
The draft added microbial contamination to microcrystalline cellulose after a loss on drying.
As per the newly added microbial contamination, “The total aerobic viable count is not more than 1000 cfu per g and the total fungal count is not more than 100 cfu per g. 1 g is free from Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa and 10 g is free from Salmonella and Shigella.”
Similarly, the IPC introduced aerobic viable count and fungal count to microbial contamination of starch.
The newly added draft amendment says “The total aerobic viable count is not more than 1000 cfu per g, the total fungal count is not more than 100 cfu per g, determined by plate count. 1 g is free from Escherichia coli and 10 g is free from Salmonella and Shigella.” Earlier aerobic viable count and fungal count were not mentioned in IP.
Furthermore, as per the new draft amendment, bacterial endotoxin will be counted in phenylephrine hydrochloride rather than phenylephrine injection.
It introduced changes from ‘not more than 25.0 endotoxin units per mg of phenylephrine’ to ‘not more than 25.0 endotoxin units per mg of phenylephrine hydrochloride’ in the Phenylephrine Injection monograph in IP 2022. Bacterial endotoxins are a component of the cell wall of gram-negative bacteria.
In August 2022 IPC came up with a revised draft general chapter on microbiology in the IP which included revised bacterial endotoxin, revised effectiveness of antimicrobial preservatives, and revised microbial contamination in non-sterile products.
Latest Circulars: (IPC) Indian Pharmacopoeia Commission
Latest Notifications regarding Pharmaceuticals
Latest on National Formulary of India (NFI)
IPC adds 7 new Veterinary Monographs, 8 new Chemical Monographs to IP 2022
IPC alerts about Cefoperazone induced coagulopathy
IPC clarifies: General Chapter on ‘Uniformity of Dosage Units’ in IP 2022 not mandatory
IPC adds 5 new IP Reference Standards & 7 new Impurities to IP 2022
IPC releases revised draft general chapters on microbiology in IP
IPC flags safety alert against immunosuppressive drug Tacrolimus
IPC releases IP 2022, 92 new monograph, 27 APIs added: Read details
IPC flags safety alert against Blood Pressure drug, Losartan
IPC to include Dissolution Test in prolonged-release formulations in IP
IPC to develop & revise IP general chapters, Monographs
IPC flags safety alert against most common Drug Ibuprofen – NSAID
Pharma Industry urges IPC to defer implementation of monograph of Ferrous Ascorbate IP 2018…
USFDA issues Form 483 with one Observation to Laurus Labs
CDSCO Panel approves Tofacitinib Ointment 2% to Continue Clinical Trial Study
USFDA gives final approval for Paclitaxel injection
This State Pharmacy Council to appoint Pharmacy Inspectors
Medical Stores पर कार्रवाई: नशीली दवाई बेचने पर Licenses cancel, suspend
Two persons arrested in fake BP medicine racket
NPPA extends time limit for submission of data of Drugs & Medical Devices
USFDA gives approval to this Blood Cancer therapy
NPPA fixes retail price for diabetes drug combination Dapagliflozin & Sitagliptin
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
